Xvivo Perfusion's market value is the price at which a share of Xvivo Perfusion trades on a public exchange. It measures the collective expectations of Xvivo Perfusion AB investors about its performance. Xvivo Perfusion is trading at 20.11 as of the 28th of December 2025. This is a 3.66% up since the beginning of the trading day. The stock's lowest day price was 20.11. With this module, you can estimate the performance of a buy and hold strategy of Xvivo Perfusion AB and determine expected loss or profit from investing in Xvivo Perfusion over a given investment horizon. Check out Xvivo Perfusion Correlation, Xvivo Perfusion Volatility and Xvivo Perfusion Alpha and Beta module to complement your research on Xvivo Perfusion.
Please note, there is a significant difference between Xvivo Perfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xvivo Perfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xvivo Perfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Xvivo Perfusion 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Xvivo Perfusion's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Xvivo Perfusion.
0.00
11/28/2025
No Change 0.00
0.0
In 31 days
12/28/2025
0.00
If you would invest 0.00 in Xvivo Perfusion on November 28, 2025 and sell it all today you would earn a total of 0.00 from holding Xvivo Perfusion AB or generate 0.0% return on investment in Xvivo Perfusion over 30 days. Xvivo Perfusion is related to or competes with PolyNovo, 4DMedical, CellaVision, Swedencare, Viva Biotech, Beijing Tong, and Sosei Group. Xvivo Perfusion AB , a medical technology company, develops solutions for organ, tissue, and cell preservation and perfu... More
Xvivo Perfusion Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Xvivo Perfusion's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Xvivo Perfusion AB upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Xvivo Perfusion's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Xvivo Perfusion's standard deviation. In reality, there are many statistical measures that can use Xvivo Perfusion historical prices to predict the future Xvivo Perfusion's volatility.
At this point, Xvivo Perfusion is not too volatile. Xvivo Perfusion AB shows Sharpe Ratio of 0.0431, which attests that the company had a 0.0431 % return per unit of risk over the last 3 months. We have found twenty-one technical indicators for Xvivo Perfusion AB, which you can use to evaluate the volatility of the company. Please check out Xvivo Perfusion's Mean Deviation of 0.9901, standard deviation of 2.81, and Market Risk Adjusted Performance of (0.44) to validate if the risk estimate we provide is consistent with the expected return of 0.12%. Xvivo Perfusion has a performance score of 3 on a scale of 0 to 100. The firm maintains a market beta of -0.24, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Xvivo Perfusion are expected to decrease at a much lower rate. During the bear market, Xvivo Perfusion is likely to outperform the market. Xvivo Perfusion AB right now maintains a risk of 2.83%. Please check out Xvivo Perfusion AB variance, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Xvivo Perfusion AB will be following its historical returns.
Auto-correlation
-0.11
Insignificant reverse predictability
Xvivo Perfusion AB has insignificant reverse predictability. Overlapping area represents the amount of predictability between Xvivo Perfusion time series from 28th of November 2025 to 13th of December 2025 and 13th of December 2025 to 28th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Xvivo Perfusion AB price movement. The serial correlation of -0.11 indicates that less than 11.0% of current Xvivo Perfusion price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.11
Spearman Rank Test
-0.54
Residual Average
0.0
Price Variance
0.12
Xvivo Perfusion AB lagged returns against current returns
Autocorrelation, which is Xvivo Perfusion pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Xvivo Perfusion's pink sheet expected returns. We can calculate the autocorrelation of Xvivo Perfusion returns to help us make a trade decision. For example, suppose you find that Xvivo Perfusion has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Xvivo Perfusion regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Xvivo Perfusion pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Xvivo Perfusion pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Xvivo Perfusion pink sheet over time.
Current vs Lagged Prices
Timeline
Xvivo Perfusion Lagged Returns
When evaluating Xvivo Perfusion's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Xvivo Perfusion pink sheet have on its future price. Xvivo Perfusion autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Xvivo Perfusion autocorrelation shows the relationship between Xvivo Perfusion pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Xvivo Perfusion AB.
Other Information on Investing in Xvivo Pink Sheet
Xvivo Perfusion financial ratios help investors to determine whether Xvivo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Xvivo with respect to the benefits of owning Xvivo Perfusion security.